Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Kit for multiplex real-time quantitative PCR (polymerase chain reaction) detection of chromosome aneuploid and application of kit

A real-time quantitative and chromosomal technology, applied in the field of biomedicine, can solve the problems of complex methods for enriching fetal DNA, low accuracy of PCR reactions, and reduced sensitivity of PCR reactions, etc.

Active Publication Date: 2016-12-07
SHANGHAI JENOMED BIOTECH CO LTD
View PDF6 Cites 10 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0007] 1. The amplification of the target chromosome and the reference chromosome is limited to a single gene locus, so the sensitivity of the PCR reaction is reduced
[0008] 2. Only chromosome 21 can be used as the target chromosome, and other autosomes can be used as the reference chromosome, so only trisomy 21 can be detected, and the detection range is relatively limited
[0009] 3. The method of enriching fetal DNA is more complicated
[0010] 4. Only one fluorescence intensity threshold is used for PCR reaction in the same tube, and the accuracy of PCR reaction is not high

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Kit for multiplex real-time quantitative PCR (polymerase chain reaction) detection of chromosome aneuploid and application of kit
  • Kit for multiplex real-time quantitative PCR (polymerase chain reaction) detection of chromosome aneuploid and application of kit
  • Kit for multiplex real-time quantitative PCR (polymerase chain reaction) detection of chromosome aneuploid and application of kit

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0099] Example 1. Using mqPCR technology to detect trisomy 21 and trisomy 18

[0100] (1) Take a 5ml pregnant woman's peripheral blood sample. Before blood collection, an informed consent form was signed with each pregnant woman.

[0101] (2) Separating and removing cells from the peripheral blood sample, and digesting serum or plasma proteins from the removed cell sample to purify the DNA sample.

[0102] (3) Enrichment of free DNA fragments less than 500 bp from the fetus to 50-100% by filtration, centrifugation, methylation separation and other methods.

[0103] (4) Divide the enriched DNA samples into an experimental group and a control group, where:

[0104] In the experimental group, using the enriched DNA sample as a template, qPCR was performed with the target chromosome gene such as the n1 primer pair of chromosome 21, and the C was recorded T Value, denoted as C TA (Chromosome 21); Among them, the n1 pairs of gene primers selected on chromosome 21 are Usp25(NCBI#NM_001283041)...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a kit for multiplex real-time quantitative PCR (polymerase chain reaction) detection of chromosome aneuploid and application of the kit. The kit comprises n1 primer pairs used for amplifying multiple genes and non-genetic locus of a target chromosome and related probes and n2 primer pairs used for amplifying multiple genes and non-genetic locus of a reference chromosome and related probes, wherein the target chromosome is a chromosome subject to chromosome quantitative variation diseases, the reference chromosome is one or multiple chromosomes, and n1 and n2 are greater than or equal to 1 respectively. The kit can be used for noninvasive prenatal screening of Down's syndrome, Edward's syndrome, PaDow's syndrome and other chromosome abnormality diseases of pregnant women. The kit has the advantages of early stage, safety, noninvasiveness, accuracy, quickness and suitability for large-scale detection and clinical application, intrauterine infection, abortion and death of fetuses at middle and late stages of pregnancy of women can be avoided, and the objective of bearing and rearing better children is achieved.

Description

Technical field [0001] The present invention belongs to the field of biomedical technology, and specifically relates to a multiplex real-time quantitative PCR (Multiplex real-time quantitative PCR, mqPCR) detection of chromosome aneuploidy using early, safe, non-invasive, accurate, fast, suitable for large-scale detection and clinical application The kit and its application. The kit performs non-invasive prenatal testing (NIPT) for normal pregnant women, including Down syndrome, Edward's syndrome, Patau's syndrome and other polyploid chromosomal diseases. Background technique [0002] There are about 900-1.2 million new birth defects in China each year, accounting for about 4-6% of the total number of births. Of the more than 80 million disabled people, about 30 million are caused by birth defects. Birth defects have become an important cause of illness, disability and even death in children, among which chromosomal abnormalities are the main diseases. Pre-pregnancy and early ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12Q1/68C12N15/11
CPCC12Q1/686C12Q1/6883C12Q2537/143C12Q2561/113C12Q2545/114C12Q2563/107C12Q2531/113
Inventor 黄跃进魏艳杨盼
Owner SHANGHAI JENOMED BIOTECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products